Search Results
Nov 07, 2025, 04:46 ET Automotive Cybersecurity Market Worth USD 14 Bn by 2030 Amid Rising Connected Vehicle Use and Data Security Mandates, Says Mordor Intelligence
Post-Quantum Cryptography Market - The post-quantum cryptography market is valued at USD 0.88 billion in 2025 and projected to reach USD 4.60 billion
More news about: Mordor Intelligence Private Limited
Nov 07, 2025, 04:30 ET LEPAS Elegant Technology Safeguards Every Elegant Journey with Global Five-Star Safety Standards
LEPAS reinterprets Euro NCAP's four independent modules into a crash-scenario-based four-stage framework—risk prediction, collision protection, and post-accident rescue—creating a closed-loop and highly robust safety system. In body-structure safety, Elegant Technology establishes
More news about: Chery Group
Nov 07, 2025, 03:47 ET LEPAS Elegant Technology Safeguards Every Elegant Journey with Global Five-Star Safety Standards
LEPAS reinterprets Euro NCAP's four independent modules into a crash-scenario-based four-stage framework—risk prediction, collision protection, and post-accident rescue—creating a closed-loop and highly robust safety system. In body-structure safety, Elegant Technology establishes
More news about: Chery Group
Nov 07, 2025, 01:02 ET SERES Resmi Catat Saham di HKEX, Manfaatkan Dua Platform Pasar Modal "A+H" untuk Ekspansi Global
Chongqing Industrial Chongqing Industrial Mother Fund (Chongqing Industrial Investment Fund of Funds (FoF), Linyuan Fund, GF Fund, Schroders, China Post Wealth, dan Xingyu Hong Kong. Dukungan luas dari investor global ini mencerminkan kepercayaan terhadap potensi pertumbuhan dan kualitas perkembangan
More news about: SERES
Nov 07, 2025, 00:00 ET SERES、香港証券取引所に正式上場、デュアル「A+H」資本プラットフォームを活用してグローバルな展開を加速
注目すべきことに、今回の公募にはChongqing Industrial Mother Fund（Chongqing Industrial Investment Fund of Funds（FoF））を含む22のコーナーストーン投資家が参加しました。Linyuan Fund、GF Fund、Schroders、China Post Wealth、そしてXingyu Hong Kongなどが名を連ねており、これはSERESの力強い成長見通しと高品質な発展が世界の資本市場から広く認められていることを示しています。このような強力な投資家からの支持は、同社の企業価値の再評価を促し、SERESの投資価値に新たなベンチマークを確立するとともに、資金調達能力と資本効率をさらに高めることが期待されています。
More news about: SERES
Nov 06, 2025, 23:37 ET Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE®
More news about: Halozyme Therapeutics, Inc.
Nov 06, 2025, 20:40 ET Seres oficiálně kótován na HKEX, využívá duální kapitálovou platformu „A+H" k podpoře globálního růstu
investorů, mezi nimiž byli Chongqing Industrial Mother Fund (Chongqing Industrial Investment Fund of Funds) (FoF), Linyuan Fund, GF Fund, Schroders, China Post Wealth a Xingyu Hong Kong, což podtrhuje široké uznání silného růstového potenciálu a kvalitního rozvoje společnosti SERES ze strany globálních kapitálových
More news about: SERES
Nov 06, 2025, 20:19 ET Study Published in JAMA Dermatology Validates Enspectra Health's Cross-Modal Imaging System for Noninvasive Visualization of Histologic Skin Features
cellular features noninvasively has broad implications for dermatology, including aesthetics. Cross-modal imaging may support pre-treatment assessment, post-treatment monitoring, and personalized aesthetic planning by revealing changes in cellular structure, collagen integrity, elastosis, and pigmentation.
More news about: Enspectra Health
Nov 06, 2025, 18:29 ET ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman
Friday, September 12, cratered to close at just $1.02 per share on September 15—a catastrophic one-day decline of 83.2%. In its post-announcement comments, the company stated that it would engage with the Food and Drug Administration (FDA) to determine a path forward, acknowledging
More news about: Hagens Berman Sobol Shapiro LLP
Nov 06, 2025, 18:14 ET Red Post Energy is proud to announce that Brigadier General Blaine D. Holt, U.S Air Force (Ret.), has joined our Advisory Board. As President Donald J. Trump and Secretary Christopher Wright set out to restore American energy dominance, Red Post Energy is answering the call.
aligns perfectly with Red Post Energy's mission to provide stable, domestic, and defense-aligned energy solutions across the United States. "Energy is the foundation of America's strength — economic, military, and moral," said General Holt. "Red Post Energy's commitment to modernizing
More news about: Red Post Energy
Nov 06, 2025, 17:07 ET DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
0.36-0.67; P<0.001). Today, most physicians use the Mayo 2018 criteria (20/2/20) to assess risk status in patients with smoldering myeloma. In a post hoc analysis of AQUILA, 41 percent of patients met the Mayo 2018 HR-SMM classification. Among these patients, median PFS was not reached in the DARZALEX
More news about: Johnson & Johnson
Nov 06, 2025, 17:05 ET Tucows Delivers Strong Results in Q3 And Reiterates Full-Year Financial Guidance
prospective investors can submit questions to Tucows' management at [email protected]. Management will post responses to questions in an audio recording and transcript to the Company's website at
More news about: Tucows Inc.
Nov 06, 2025, 16:39 ET Quantinuum Announces Commercial Launch of New Helios Quantum Computer that Offers Unprecedented Accuracy to Enable Generative Quantum AI (GenQAI)
collaboration, while a new startup partner program will invite developers to build and scale third party applications on Helios. A blog post with more details on Helios can be read
More news about: Quantinuum
Nov 06, 2025, 16:35 ET Quantinuum Announces Commercial Launch of New Helios Quantum Computer that Offers Unprecedented Accuracy to Enable Generative Quantum AI (GenQAI)
collaboration, while a new startup partner program will invite developers to build and scale third party applications on Helios. A blog post with more details on Helios can be read
More news about: Quantinuum
Nov 06, 2025, 16:30 ET Pangaea Logistics Solutions Ltd. Reports Financial Results for the Third Quarter Ended September 30, 2025
logistics model to deliver value across the supply chain. In addition to operating the world's largest high ice-class dry bulk fleet of Panamax and post-Panamax vessels, the Company provides stevedoring services and maintains robust port and terminal operations capabilities. Following the successful
More news about: Pangaea Logistics Solutions LTD
Nov 06, 2025, 16:15 ET Brookdale Announces Third Quarter 2025 Results and Increases Adjusted EBITDA Annual Guidance
SUPPLEMENTAL INFORMATION The Company will post on its website at
More news about: Brookdale Senior Living Inc.
Nov 06, 2025, 16:15 ET EOG Resources Reports Third Quarter 2025 Results
Repurchased $440 million of stock Closed on the acquisition of Encino for $5.7 billion, subject to post–closing adjustments Issued $3.5 billion of senior notes in conjunction with the Encino acquisition
More news about: EOG Resources, Inc.
Nov 06, 2025, 16:10 ET Metallus Announces Third-Quarter 2025 Results
invoice. These additional surcharge line items adjust base prices to match cost fluctuations due to market conditions. Each month, the company will post on the surcharges page of its external website, as well as our customer portal, the scrap, alloy, and energy surcharges that will be applied (as a separate
More news about: Metallus Inc.
Nov 06, 2025, 16:05 ET Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025
treatment for an underlying condition (i.e., asthma, gastroesophageal reflux disease, non-asthmatic eosinophilic bronchitis, upper airway cough syndrome, or post-nasal drip) and includes unexplained chronic cough. There are ~2-3 million U.S. patients with RCC, and it is believed to be associated with cough reflex
More news about: Trevi Therapeutics, Inc.
Nov 06, 2025, 16:05 ET Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
integration costs directly related to mergers and acquisitions, including: (i) legal, consulting, and accounting fees associated with acquisitions; (ii) post-acquisition employee retention bonuses; (iii) (gain)/loss from changes in the fair value of contingent consideration liabilities resulting from acquisitions;
More news about: Ginkgo Bioworks
Nov 06, 2025, 16:05 ET Solventum Reports Third Quarter 2025 Financial Results
Other represents sales impact from acquisitions and divestitures measured separately for the first 12 months post-transaction. Divestiture represents lost sales from the Company's Purification and Filtration business that was sold in September 2025.
More news about: Solventum
Nov 06, 2025, 16:05 ET GoPro Announces Third Quarter Results
Pacific Time (5 p.m. Eastern Time) to discuss the Company's financial results. Prior to the start of the call, the Company will post Management Commentary on the "Events & Presentations" section of its investor relations website at
More news about: GoPro, Inc.
Nov 06, 2025, 16:05 ET FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2025 RESULTS
Pre-Recorded Management Remarks and Question and Answer Webcast In conjunction with this release, Flowers Foods will post pre-recorded management remarks and a supporting slide presentation on the investors page of flowersfoods.com. The company will host a live question
More news about: Flowers Foods, Inc.
Nov 06, 2025, 16:01 ET AKAMAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
amortization of acquired intangible assets from its non-GAAP financial measures to provide investors with a consistent basis for comparing pre- and post-acquisition operating results. Stock-based compensation and amortization of capitalized stock-based
More news about: Akamai Technologies, Inc.
Nov 06, 2025, 15:49 ET LifeCare Home Health Family Expands Hospice Footprint with Acquisition of Infinity Hospice Care
systems, and shared values." For LifeCare, this acquisition represents a continued investment in building a scalable, integrated post-acute care network focused on quality, compassion, and innovation. The addition of Infinity's inpatient hospice unit offers new capabilities to support
More news about: LifeCare Home Health Family